| Metric | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥338.9B | ¥303.1B | +11.8% |
| Operating Income / Operating Profit | ¥36.0B | ¥25.0B | +43.9% |
| Ordinary Income | ¥38.1B | ¥26.6B | +42.9% |
| Net Income / Net Profit | ¥25.6B | ¥18.4B | +39.0% |
| ROE | 11.9% | 8.9% | - |
For FY2026 Q3 cumulative results, revenue was ¥338.9B (YoY +¥35.8B +11.8%), operating income was ¥36.0B (YoY +¥11.0B +43.9%), ordinary income was ¥38.1B (YoY +¥11.4B +42.9%), and net income was ¥25.6B (YoY +¥7.2B +39.0%), achieving top- and bottom-line growth driven by the realization of operating leverage. Gross profit was ¥63.8B, up ¥13.3B YoY, and gross margin improved by 2.1pt to 18.8% (prior year 16.7%). SG&A increased by ¥2.3B to ¥27.8B, which was absorbed, raising the operating margin 2.3pt to 10.6% (prior year 8.3%). Non-operating income was ¥3.0B (including ¥1.9B in subsidy income), exceeding interest expense of ¥0.9B and supporting gains at the ordinary income level. Net margin improved 1.5pt to 7.6% (prior year 6.1%), and the effective tax rate of 32.7% remained within the normal range. ROE remained healthy at 11.9%, supported by improved profitability and moderate financial leverage (2.53x).
[Revenue] Revenue of ¥338.9B represents an 11.8% YoY increase, driven by the core Nursing Care Business with ¥323.5B (+12.5%) delivering double-digit growth. Other businesses were ¥15.4B, roughly flat. Gross profit expanded at a faster pace than revenue to ¥63.8B (+26.4%), and gross margin improved 2.1pt to 18.8% (prior year 16.7%). Revenue growth was mainly due to higher occupancy at existing homes and price normalization, with contributions from property acquisitions related to new home openings (Construction in progress +¥2.9B, Land +¥13.3B). Revisions to care fees and subsidy income of ¥1.9B also provided some uplift, but core earnings improvements were the primary driver.
[Profitability] Operating income of ¥36.0B (+43.9%) reflects gross profit growth that substantially outpaced SG&A expansion of ¥27.8B (+9.2%), improving the operating margin 2.3pt to 10.6% (prior year 8.3%). Ordinary income of ¥38.1B (+42.9%) was supported by non-operating income of ¥3.0B (prior year ¥2.3B), which offset an increase in interest expense to ¥0.9B (prior year ¥0.7B). Extraordinary items were immaterial (extraordinary gains ¥0.6B, extraordinary losses ¥0.0B) with limited impact on net income. After deducting corporate taxes of ¥12.4B, net income was ¥25.6B (+39.0%), achieving revenue and profit growth.
The Nursing Care Business reported revenue of ¥323.5B (prior year ¥287.7B, +12.5%), segment profit of ¥45.3B (prior year ¥33.9B, +33.8%), and margin of 14.0% (prior year 11.8%), with substantial increases in both revenue and profit. The 2.2pt margin improvement was likely driven by higher occupancy, price normalization, and optimization of cost allocation. Other businesses recorded revenue of ¥15.4B, roughly flat, with segment profit of ¥0.3B (prior year ¥0.3B), remaining small scale. Corporate expenses were ¥9.6B (prior year ¥9.2B), largely unchanged, and the Nursing Care Business’s improved earnings power drove group-level profit growth.
[Profitability] Operating margin 10.6% (prior year 8.3%) and net margin 7.6% (prior year 6.1%) both improved, and ROE remained healthy at 11.9%. ROE decomposition: net margin 7.6% × total asset turnover 0.621 × financial leverage 2.53x, with net margin improvement the main contributor. [Cash Quality] Cash and deposits stood at ¥75.0B but were closely matched by short-term borrowings of ¥73.8B, leaving the current ratio at 87.1%, below 1.0. Working capital was negative ¥32.9B, but contract liabilities of ¥124.5B (advance-receipt nature) are large and partially support liquidity. [Investment Efficiency] Total asset turnover improved slightly to 0.621 (prior year 0.579), indicating rising asset efficiency. Construction in progress was ¥3.6B (prior year ¥0.7B) and land ¥42.8B (prior year ¥29.4B), indicating ongoing investments for new home openings; timing of earnings conversion post-startup merits attention. [Financial Soundness] Equity ratio was 39.5% (prior year 39.4%), a mid-level position. Of interest-bearing debt ¥128.3B, short-term borrowings increased sharply to ¥73.8B (+¥15.9B +27.5%), resulting in a high short-term debt ratio of 57.5%. Interest coverage was very high at 38.3x, indicating strong interest-paying capacity, but the debt-to-equity ratio of 1.53x and Debt/Capital 37.3% reflect high reliance on short-term debt, making refinancing risk and maturity mismatch management key issues.
Cash flow statement data were not provided, but balance sheet movements indicate cash trends: cash and deposits decreased to ¥75.0B (prior year ¥91.5B, -¥16.5B), while short-term borrowings rose materially to ¥73.8B (prior year ¥57.9B, +¥15.9B). This composition suggests growth investments (Construction in progress +¥2.9B, Land +¥13.3B) and working capital needs may have been financed with short-term liabilities. Contract liabilities of ¥124.5B decreased by ¥4.3B from ¥128.8B, suggesting some moderation in advance-receipt inflows. Long-term borrowings declined to ¥54.5B (prior year ¥61.8B, -¥7.3B), indicating a shift toward shorter-term borrowings. Retained earnings increased to ¥159.5B (prior year ¥151.6B, +¥7.9B), with most of the ¥25.6B net income retained. Subsidy income of ¥1.9B is included in non-operating income but is limited in scale, and the profit structure remains core-earnings-led. Given the high reliance on short-term liabilities, liquidity stability and execution of refinancing plans will determine future cash generation capacity.
Overall, the quality of earnings is good. Operating income of ¥36.0B flowed through to ordinary income of ¥38.1B and net income of ¥25.6B, showing consistent profitability improvement from operating to bottom-line. Of the ¥3.0B in non-operating income, ¥1.9B was subsidy income and ¥0.2B was interest income—mainly recurring items—so one-off uplift effects are limited. Extraordinary items were minor (extraordinary gains ¥0.6B, extraordinary losses ¥0.0B), so divergence between net income and ordinary income is small. Comprehensive income of ¥26.6B exceeded net income by ¥1.0B, with ¥1.1B in valuation gains on securities contributing positively. On accruals, bonus reserves increased to ¥4.7B (prior year ¥1.8B, +¥2.9B) and other personnel-related provisions rose, but these remain within an acceptable range amid profit growth and do not threaten sustainability. Interest burden ratio 1.025 (= (Ordinary Income ¥38.1 + Interest Expense ¥0.9) / Ordinary Income ¥38.1) and tax burden ratio 0.673 (= Net Income ¥25.6 / Profit Before Tax ¥38.0) are both within appropriate ranges, suggesting limited qualitative erosion of earnings from a five-factor DuPont perspective.
Full Year / FY guidance: revenue ¥485.9B (YoY +4.1%), operating income ¥44.6B (YoY +16.0%), ordinary income ¥46.1B (YoY +14.7%), net income ¥30.9B (YoY ▲10.8%). Progress for the Q3 cumulative period stands at: revenue 69.8%, operating income 80.8%, ordinary income 82.6%, net income 82.8%. Compared to a standard progress of 75%, revenue is somewhat behind while profits show outperformance, suggesting gross margin and operating margin improvements are absorbing cost increases and securing profits at a faster pace than the full-year plan. Contract liabilities of ¥124.5B correspond to roughly 25.6% of annual revenue, providing some support to future revenue visibility. No revisions to the full-year guidance have been made; depending on Q4 results there is room to widen profit upgrades.
An interim dividend of ¥20 (including a ¥3 commemorative dividend for the 20th anniversary of the opening of the first home) was paid at the end of Q2. Based on net income of ¥25.6B for the period, the annualized total dividend is approximately ¥6.5B, implying a payout ratio of about 25.6%, a conservative level. With FY EPS guidance of ¥94.59, the dividend forecast of ¥17 (payout ratio ~18.0%) is consistent, reflecting a return policy that balances profit growth and internal reserves. No share buybacks have been disclosed; dividend payments remain the primary shareholder return. Given the high short-term debt ratio of 57.5%, the company appears to prioritize growth investment and financial stabilization (lengthening debt maturities) while maintaining sustainable dividends.
Short-term debt concentration risk: Short-term borrowings rose sharply to ¥73.8B (YoY +27.5%), with a short-term debt ratio of 57.5% and current ratio 87.1%, indicating high dependence on short-term funding. Failure to refinance or a deterioration in financial market conditions could strain liquidity. Although interest coverage of 38.3x indicates strong ability to service interest, resolving maturity mismatches (shifting to long-term debt, dispersing repayment schedules) remains a challenge.
Gross margin decline risk: Despite improvement to 18.8% (prior year 16.7%), the company operates in a low-margin environment below 20%. If personnel cost inflation, intensified recruitment competition, or unfavorable care fee revisions occur, cost of sales and SG&A ratios could rise, reversing the operating margin improvement. SG&A at ¥27.8B (8.2% of revenue) is controlled, but if gross profit growth slows, operating leverage could turn adverse.
Business concentration risk: The Nursing Care Business accounts for 95.4% of revenue and nearly all segment profit, creating single-business dependency. Sector-specific risks—care fee system revisions, re-emergence of infection-response costs, regulatory tightening—could significantly impact consolidated performance, and portfolio diversification is limited.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 10.6% | 8.2% (3.6%–18.0%) | +2.5pt |
| Net Margin | 7.6% | 6.0% (2.2%–12.7%) | +1.6pt |
The company’s profitability exceeds industry medians, with favorable positioning in both operating and net margins.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 11.8% | 10.4% (-1.1%–19.5%) | +1.4pt |
Revenue growth modestly outpaces the industry median, maintaining a stable growth trajectory.
※ Source: Company aggregation
Realization of operating leverage and profitability improvement: Gross margin 18.8% (YoY +2.1pt) and operating margin 10.6% (YoY +2.3pt) show multi-period improvement in profitability. Higher occupancy at existing homes and price normalization absorbed cost increases, producing a substantial YoY operating income rise of +43.9%. If this improvement trend persists, maintenance of ROE at 11.9% and further shareholder value enhancement are expected.
High short-term debt composition and liquidity management: Short-term borrowings ¥73.8B (YoY +27.5%), short-term debt ratio 57.5%, current ratio 87.1% show high reliance on short-term funding and a structure prone to maturity mismatch risk. Although interest coverage 38.3x indicates strong interest-paying capacity, balancing future growth investments (construction in progress, land acquisitions) with lengthening and diversifying debt maturities will be key to medium-term financial stability.
Profit progress exceeding full-year guidance: Q3 cumulative operating income progress 80.8% and net income progress 82.8% exceed the standard 75% pace, indicating strong profit performance. Gross margin improvement and cost control have been effective, and depending on Q4 results there is upside potential to the full-year forecast. Contract liabilities of ¥124.5B support future revenues and reflect a stable order environment.
This report is an AI-generated earnings analysis document produced by analyzing XBRL financial statement data. It does not constitute an investment recommendation for any particular security. Industry benchmarks are reference information compiled by the Company based on public financial disclosures. Investment decisions are your responsibility; please consult a professional advisor as needed.